European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects

MPT de Wit, SE Berlo, GJ Aanerud, D Aletaha… - Annals of the …, 2011 - ard.bmj.com
Objective To develop recommendations to enable successful inclusion of the patient
perspective in European League Against Rheumatism (EULAR)-funded scientific research …

Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting

C Tur, M Moccia, F Barkhof, J Chataway… - Nature Reviews …, 2018 - nature.com
Increasing numbers of drugs are being developed for the treatment of multiple sclerosis
(MS). Measurement of relevant outcomes is key for assessing the efficacy of new drugs in …

The Copenhagen Hip and Groin Outcome Score (HAGOS): development and validation according to the COSMIN checklist

K Thorborg, P Hölmich, R Christensen… - British journal of sports …, 2011 - bjsm.bmj.com
Background Valid, reliable and responsive Patient-Reported Outcome (PRO) questionnaires
for young to middle-aged, physically active individuals with hip and groin pain are lacking …

An introduction to item response theory for patient-reported outcome measurement

TH Nguyen, HR Han, MT Kim, KS Chan - The Patient-Patient-Centered …, 2014 - Springer
The growing emphasis on patient-centered care has accelerated the demand for high-
quality data from patient-reported outcome (PRO) measures. Traditionally, the development …

[PDF][PDF] Patient-reported outcome measures

K Williams, J Sansoni, M Darcy… - … on Safety and …, 2016 - safetyandquality.gov.au
This is the third in a three part series of reports presenting current evidence on
patientreported outcome measures (PROMs). It presents findings from systematic analysis of …

Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction

SM Joseph, E Novak, SV Arnold, PG Jones… - Circulation: Heart …, 2013 - Am Heart Assoc
Background—Despite the growing epidemic of heart failure with preserved ejection fraction
(HFpEF), no valid measure of patients' health status (symptoms, function, and quality of life) …

Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences

M de Wit, T Abma, M Koelewijn-van Loon, S Collins… - BMJ open, 2013 - bmjopen.bmj.com
Objective To assess the inclusion of patients as international research partners in Outcome
Measures in Rheumatology (OMERACT) conferences and how this has influenced the …

Evaluating the reliability and construct validity of the Eckardt symptom score as a measure of achalasia severity

TH Taft, DA Carlson, J Triggs, J Craft… - …, 2018 - Wiley Online Library
Background Achalasia is a disease of mechanical esophageal dysfunction characterized by
dysphagia, chest pain, regurgitation, and malnutrition. The Eckardt symptom score (ESS) is …

Participation in psychosocial oncology and quality-of-life research: a systematic review

CE Wakefield, JE Fardell, EL Doolan… - The Lancet …, 2017 - thelancet.com
Quality-of-life and psychosocial oncology studies that have low participation might have less
precision, less statistical power, and can have non-response bias. In this systematic Review …

Proportion of patients reporting acceptable symptoms or treatment failure and their associated KOOS values at 6 to 24 months after anterior cruciate ligament …

LH Ingelsrud, LP Granan, CB Terwee… - … American journal of …, 2015 - journals.sagepub.com
Background: The proportion of patients perceiving their symptoms as either acceptable or as
a failure of treatment after anterior cruciate ligament reconstruction (ACLR) is unknown …